-

Viz.ai Strengthens Information Security with ISO-27001:2022 Certification

Certification validates Viz.ai One platform as trusted and secure for health systems

SAN FRANCISCO--(BUSINESS WIRE)--Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced the successful completion of the International Organization for Standardization (ISO) ISO-27001:2022 certification as well as additional ISO certificates including 22301:2019, 27017:2015, 27018:2019, 27032:2012, 27701:2019, and 27799:2016. Achieving this rigorous auditing standard further validates Viz.ai’s systematic and comprehensive approach to information security management practices and business continuity management systems.

“We’re proud to have achieved seven ISO certificates for the Viz.ai One platform without any major findings,” said Tom Vaknin, Chief Information Security Officer at Viz.ai. “Information security is critical for our customers and our organization. This milestone demonstrates our ongoing commitment to uphold the confidentiality, integrity, and availability of information assets as well as continued enhancement of our information security processes.”

ISO certificates are awarded to organizations that meet stringent criteria for establishing, implementing, maintaining, and continually improving information security management practices. Viz.ai received seven certificates for business continuity management, information security management system, process information in the cloud, processing Personally Identifiable Information (PII) in the cloud, cybersecurity, information security in health, and privacy information management system.

ISO is an independent, non-governmental international organization that develops and publishes international standards to ensure the quality, safety, efficiency, and interoperability of products, services, and systems. The certificates confirm that Viz.ai has effective information security management systems in place.

These ISO certifications follow Viz.ai’s successful completion of its SOC 2 Type 2 + HIPAA audit, which was announced in February of 2024. To learn more about Viz.ai’s robust security measures and compliance certifications, please visit the Viz.ai Trust Center.

About Viz.ai

Viz.ai is the pioneer in the use of AI algorithms and machine learning to increase the speed of diagnosis and care across 1,600+ hospitals and health systems in the U.S. and Europe. The AI-powered Viz.ai One™ is an intelligent care coordination solution that identifies more patients with a suspected disease, informs critical decisions at the point of care, and optimizes care pathways and helps improve outcomes. Backed by real-world clinical evidence, Viz.ai One delivers significant value to patients, providers, and pharmaceutical and medical device companies. For more information visit viz.ai.

Contacts

Viz.ai


Release Versions

Contacts

Social Media Profiles
More News From Viz.ai

Viz.ai Appoints Jallel Harrati as Chief Revenue Officer to Accelerate Enterprise Growth

SAN FRANCISCO--(BUSINESS WIRE)--Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced the appointment of Jallel Harrati as Chief Revenue Officer (CRO). Harrati joins Viz.ai at an exciting stage as the company scales adoption of Viz Assist, its multimodal AI agent platform, across an established base of 2,000 hospitals. Viz.ai has long been the leader in building and deploying AI Care Pathways that help ensure more patients receive guideline-based...

Viz.ai and Salesforce Collaborate to Transform Pharma Engagement With Real-Time Clinical Intelligence for Agentforce

SAN FRANCISCO--(BUSINESS WIRE)--Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced the launch of a new real-time clinical intelligence service for Salesforce’s Agentforce Life Sciences. These services will power new and existing agentic solutions for life sciences customers, including a data integration that will bring Viz.ai’s real-time data, triggers, and clinical intelligence layer from across a network of nearly 2,000 hospitals covering 230...

Viz.ai Closes 2025 with Record Scale and Patient Impact, Achieving Profitability in Its Healthcare Business while Accelerating Life Sciences Growth

SAN FRANCISCO--(BUSINESS WIRE)--Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced a milestone year marked by record growth in its provider footprint, profitability across its healthcare business, the launch of Viz Oncology and Viz Assist, and the doubling of its life sciences business over the past 18 months. Viz.ai is now adopted in nearly 2,000 hospitals across the United States, including the majority of the 50 largest health systems, suppo...
Back to Newsroom